Adma Biologics

ASCENIV

Manufacturer:

Adma Biologics

Asceniv HCPCS:

J1554

HCPCS Code Descriptor:

Injection, immune globulin (asceniv), 500 mg

Category:

J Code

Asceniv NDCs:

69800-0250-01

Primary Type:

Immunoglobulin

Generic/Specialty Status:

Single-Source

Route of Administration:

Intravenous

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Asceniv:

ASCENIV is an Immunoglobulin drug manufactured by Adma Biologics and administered via the Intravenous route of administration. The J Code: J1554 is aligned to the drug ASCENIV.

ACCESS PRICING AND MORE BY REGISTERING

J1554 Added Date:

April 1, 2021

J1554 Effective Date:

April 1, 2021

J1554 Termination Date:

HCPCS Active

Asceniv billing and coding information can be found through Adma Biologics at the link below:
Asceniv patient assistance information can be found through ADMA ADvantage Ig at the URL: https://www.asceniv.com/access
ASCENIV prescribing information can be found at the link below:
Our team has not yet identified a source of side effects information for ASCENIV. Please check back in a few weeks.